Can Peptides Really Absorb Under the Tongue?

Short answer: Yes — the sublingual route is real, established delivery science that works well for the right molecules. The tissue under your tongue is thin, blood-rich and bypasses first-pass liver metabolism, which is why approved medicines have used it for decades. How well any specific peptide crosses depends on the molecule.

If you've gone looking for a straight answer here, you've probably noticed the internet can't agree with itself. One forum thread calls sublingual peptides a scam; a brand page quotes sky-high percentages. The truth is more interesting than either — and it starts with anatomy that's genuinely on your side.

The sublingual route: real pharmacology, decades deep

Let's start with what the skeptics get wrong. Sublingual delivery is not a wellness-industry invention. It's an established route in pharmaceutical science, used for generations in regulated drug products — most famously nitroglycerin, placed under the tongue precisely because it works there.

The anatomy earns its reputation. The floor of the mouth is lined with some of the thinnest epithelium in the oral cavity, sitting directly on a dense capillary bed. Critically, those vessels drain toward general circulation without routing through the liver first. A swallowed capsule takes the long road — stomach acid, digestive enzymes, the intestinal wall, then the portal vein to the liver, which dismantles much of many compounds before they ever circulate. That's first-pass metabolism, and it's brutal on peptides specifically, because digestion is machinery built to break amino-acid chains apart. A compound that crosses the mouth tissue skips that gauntlet entirely. We've unpacked the full mechanics in our sublingual delivery science explainer.

And this isn't only theory for supplement-style ingredients: in a randomized crossover human trial, sublingual glutathione significantly raised plasma glutathione levels while the same dose swallowed orally did not (Schmitt et al., Redox Biology 2015, PMC4536296) [published human data]. That's the route doing exactly what the anatomy promises — in people.

Molecule size: the friendly gatekeeper

Whether a molecule passively crosses the oral mucosa depends on its size and charge. Small, uncharged molecules cross readily; larger or charged ones cross less easily. Here are real molecular weights for compounds people actually ask about:

• Niacin: ~123 Da — small. Crosses mucosal tissue well.
• NMN: ~334 Da — borderline, with a well-evidenced swallowed backup route: oral NMN and NR have raised blood NAD+ in human trials [published human data].
• Intact NAD+: ~663 Da, charged — a tougher mucosal candidate, and the reason the early sublingual NAD+ research now emerging matters so much.
• BPC-157: ~1,419 Da — larger by mucosal standards, but with an unusual saving grace: it's stable in gastric fluid rather than being instantly digested [preclinical evidence]. More on why that matters below.

The pattern is genuinely empowering: "peptides" isn't one category with one absorption story — and formulators who understand the spectrum can design around it.

The dual-route advantage

Here's what actually happens when a strip dissolves under your tongue: part of the active absorbs through the mucosa during dwell time, and the rest mixes with saliva and gets swallowed. Loading a strip is not the same as absorbing a strip — and the smart way to read that is as two routes working for you instead of one:

• For BPC-157, the swallowed fraction is far from wasted. Because it's gastric-stable, oral and GI-tract activity is where much of the animal research has focused — including studies administering it in drinking water [preclinical evidence]. For this molecule, the dual route is arguably a feature, not a compromise.
• For smaller compounds like niacin and borderline ones like NMN, the mouth route does meaningful work, and the swallowed fraction has its own human evidence behind it.
• For large, digestion-fragile peptides, what crosses in the mouth carries the load — which is why delivery-system design (film base, excipients, dwell time) is where serious products differentiate.

The honest context, once

Plainly, because you deserve the whole canvas: no published human pharmacokinetic study has yet measured absorption for these specific strip products, so nobody — including us — can honestly quote you a precise absorption percentage for them. The 80–92% figures circulating in this category trace to InstaMed's own marketing materials, not to a peer-reviewed human study we can find [brand claim — unverified]. What is established: the route itself is real and medicine-proven, human sublingual data exists for compounds like glutathione [published human data], and molecule-by-molecule logic tells you where the format shines. We think that's a genuinely promising picture — we'd just rather you see the whole canvas than a cropped corner.

What the evidence shows — and what's still coming

Established:

• The sublingual route is real, long-established pharmacology: thin tissue, rich blood supply, first-pass bypass for what crosses.
• Human trial data shows sublingual delivery succeeding where swallowed delivery failed — for glutathione [published human data].
• Orally delivered NAD precursors (NR, NMN) have raised blood NAD+ in human trials [published human data].
• BPC-157 is gastric-stable and has shown oral/GI activity in animal models [preclinical evidence].

Still coming:

• Strip-specific human absorption measurements for these products — the natural next step for the category.
• Any verified absorption percentage for these strips, high or low.

Who the strip is for

The strip makes sense if you value consistency over complexity: you want support that survives travel days, busy weeks, and a life that doesn't pause for a protocol. It's also the natural entry point if needles were the thing keeping you out of the category. What strips deliver, verifiably, is a legitimate format: needle-free, pre-measured (each BPC-157 strip carries a labeled 500 mcg; each NAD+ strip a labeled 100 mg), portable, and dual-route by design.

The bottom line

Do sublingual peptides work? The route is established science, the anatomy is on your side, human sublingual successes are already on the books, and the smartest formulations are built molecule-by-molecule around the size spectrum. For the reader hoping the answer was "yes, with real science behind it" — it is.

---

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

This content is for educational purposes only and is not medical advice. Consult a licensed healthcare provider before starting any new product. Individual results vary.